Calcium Folinate Ebewe New Zealand - English - Medsafe (Medicines Safety Authority)

calcium folinate ebewe

novartis new zealand ltd - calcium folinate pentahydrate 12.71 mg/ml equivalent to 10 mg/ml folinic acid - concentrate for injection - 10 mg/ml - active: calcium folinate pentahydrate 12.71 mg/ml equivalent to 10 mg/ml folinic acid excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - · as rescue therapy to reduce toxicity following high-dose methotrexate therapy. · has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions · overdosage of methotrexate and in impaired methotrexate elimination · reducing the toxicity and circumventing the effect of folic acid antagonists

Calcium Folinate Solution for Inj/Inf 10mg/ml (5ml vial) Malta - English - Medicines Authority

calcium folinate solution for inj/inf 10mg/ml (5ml vial)

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg - all other therapeutic products

Calcium Folinate Solution for Inj/Inf 10mg/ml (10ml vial) Malta - English - Medicines Authority

calcium folinate solution for inj/inf 10mg/ml (10ml vial)

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg/ml - all other therapeutic products

Calcium Folinate Solution for Inj/Inf 10mg/ml (20ml vial) Malta - English - Medicines Authority

calcium folinate solution for inj/inf 10mg/ml (20ml vial)

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg/ml - all other therapeutic products

Calcium Folinate Solution for Inj/Inf 10mg/ml (35ml vial) Malta - English - Medicines Authority

calcium folinate solution for inj/inf 10mg/ml (35ml vial)

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg/ml - all other therapeutic products

Calcium Folinate Solution for Inj/Inf 10mg/ml (50ml vial) Malta - English - Medicines Authority

calcium folinate solution for inj/inf 10mg/ml (50ml vial)

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg/ml - all other therapeutic products

Calcium Folinate Solution for Inj/Inf 10mg/ml (100ml vial) Malta - English - Medicines Authority

calcium folinate solution for inj/inf 10mg/ml (100ml vial)

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg/ml - all other therapeutic products

Calcium Folinate Sandoz New Zealand - English - Medsafe (Medicines Safety Authority)

calcium folinate sandoz

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 100 mg/10ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

Calcium Folinate Sandoz New Zealand - English - Medsafe (Medicines Safety Authority)

calcium folinate sandoz

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 1000 mg/100ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

Calcium Folinate Sandoz New Zealand - English - Medsafe (Medicines Safety Authority)

calcium folinate sandoz

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 200 mg/20ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists